Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 129 participants.

Also called NCT06018818

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 129 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06018818
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Austria, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06018818. Allocation not applicable; no masking; primary purpose treatment. Start 2023-08-23 (actual); primary completion 2025-07-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family
Condition
Bradycardia
Condition
Heart Failure
Intervention (Device)
Amvia/Solvia pacemaker family
Lead sponsor
Biotronik SE & Co. KG (class: industry)

Record details

Record id
cardio:ct-nct06018818
Content hash
a53dae63942eadfdb4ef9b9a5dc69b90dd907d18051fc20000b56df277e573b7